"Forecast expenditure for the coming quarter is estimated to be A$4.3m with approximately A$4.0m planned to be spent on R&D"
~93% spent on actually adding potential value rather than admin/overheads/pocket-lining.
Great to find a company with this sort of expenditure structure..
- Forums
- ASX - By Stock
- BOT
- Ann: Appendix 4C - quarterly
BOT
botanix pharmaceuticals limited
Add to My Watchlist
5.00%
!
2.1¢
Ann: Appendix 4C - quarterly, page-6
-
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.